Spravato® (esketamine) is a nasal spray prescribed for treatment-resistant depression. Unlike oral antidepressants, which can take several weeks to months to work, the healing effects of this medication are typically felt within hours. Relief may be felt quickly – finally offering change for those who have not responded well to traditionally prescribed medication.

Spravato® targets the glutamate system in the brain, which plays an important role in healthy brain functioning. Glutamate is a highly abundant neurotransmitter, responsible for facilitating signals between nerve cells. This process works with different pathways in the brain than traditionally prescribed medications, and often relief begins to be felt more quickly.

Research and understanding of this new approach for depression is continuing to deepen. It’s thought to create new connections in the brain, allowing for behavioral and cognitive changes to occur more readily and rapidly in patients with treatment-resistant depression. Clinical trials have shown a 69% response rate and 52% remission rate in patients treated with Spravato® with minimal side effects. 

We partner with most major insurance plans.

At Heading, we’re dedicated to providing a comprehensive care experience. Our team will help you understand your benefits and will work directly with your insurance plan to determine if you’re eligible for coverage.

During your consultation, we’ll discuss coverage, costs, payments, reimbursements or whatever else you’d like to know about. We will take it off your plate so you can begin focusing on what’s most important: you.

Monday: 8:00 AM - 4:30 PM Tuesday: 10:30 AM - 7:00 PM Wednesday: 8:00 AM - 4:30 PM Thursday: 8:00 AM - 4:30 PM Friday: 8:00 AM - 4:30 PM Saturday: CLOSED Sunday: CLOSED
Updated within the last month